PTEN Tumor-Suppressor: The Dam of Stemness in Cancer

<i>PTEN</i> is one of the most frequently inactivated tumor suppressor genes in cancer. Loss or variation in <i>PTEN</i> gene/protein levels is commonly observed in a broad spectrum of human cancers, while germline <i>PTEN</i> mutations cause inherited syndromes t...

Full description

Bibliographic Details
Main Authors: Francesca Luongo, Francesca Colonna, Federica Calapà, Sara Vitale, Micol E. Fiori, Ruggero De Maria
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/11/8/1076
_version_ 1797708837358141440
author Francesca Luongo
Francesca Colonna
Federica Calapà
Sara Vitale
Micol E. Fiori
Ruggero De Maria
author_facet Francesca Luongo
Francesca Colonna
Federica Calapà
Sara Vitale
Micol E. Fiori
Ruggero De Maria
author_sort Francesca Luongo
collection DOAJ
description <i>PTEN</i> is one of the most frequently inactivated tumor suppressor genes in cancer. Loss or variation in <i>PTEN</i> gene/protein levels is commonly observed in a broad spectrum of human cancers, while germline <i>PTEN</i> mutations cause inherited syndromes that lead to increased risk of tumors. <i>PTEN</i> restrains tumorigenesis through different mechanisms ranging from phosphatase-dependent and independent activities, subcellular localization and protein interaction, modulating a broad array of cellular functions including growth, proliferation, survival, DNA repair, and cell motility. The main target of <i>PTEN</i> phosphatase activity is one of the most significant cell growth and pro-survival signaling pathway in cancer: PI3K/AKT/mTOR. Several shreds of evidence shed light on the critical role of <i>PTEN</i> in normal and cancer stem cells (CSCs) homeostasis, with its loss fostering the CSC compartment in both solid and hematologic malignancies. CSCs are responsible for tumor propagation, metastatic spread, resistance to therapy, and relapse. Thus, understanding how alterations of <i>PTEN</i> levels affect CSC hallmarks could be crucial for the development of successful therapeutic approaches. Here, we discuss the most significant findings on <i>PTEN</i>-mediated control of CSC state. We aim to unravel the role of <i>PTEN</i> in the regulation of key mechanisms specific for CSCs, such as self-renewal, quiescence/cell cycle, Epithelial-to-Mesenchymal-Transition (EMT), with a particular focus on <i>PTEN</i>-based therapy resistance mechanisms and their exploitation for novel therapeutic approaches in cancer treatment.
first_indexed 2024-03-12T06:27:29Z
format Article
id doaj.art-dafff1cbf36044dcb85e9742a83107c0
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T06:27:29Z
publishDate 2019-07-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-dafff1cbf36044dcb85e9742a83107c02023-09-03T01:51:18ZengMDPI AGCancers2072-66942019-07-01118107610.3390/cancers11081076cancers11081076PTEN Tumor-Suppressor: The Dam of Stemness in CancerFrancesca Luongo0Francesca Colonna1Federica Calapà2Sara Vitale3Micol E. Fiori4Ruggero De Maria5Istituto di Patologia Generale, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, ItalyIstituto di Patologia Generale, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, ItalyIstituto di Patologia Generale, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, ItalyIstituto di Patologia Generale, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, ItalyDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, ItalyIstituto di Patologia Generale, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy<i>PTEN</i> is one of the most frequently inactivated tumor suppressor genes in cancer. Loss or variation in <i>PTEN</i> gene/protein levels is commonly observed in a broad spectrum of human cancers, while germline <i>PTEN</i> mutations cause inherited syndromes that lead to increased risk of tumors. <i>PTEN</i> restrains tumorigenesis through different mechanisms ranging from phosphatase-dependent and independent activities, subcellular localization and protein interaction, modulating a broad array of cellular functions including growth, proliferation, survival, DNA repair, and cell motility. The main target of <i>PTEN</i> phosphatase activity is one of the most significant cell growth and pro-survival signaling pathway in cancer: PI3K/AKT/mTOR. Several shreds of evidence shed light on the critical role of <i>PTEN</i> in normal and cancer stem cells (CSCs) homeostasis, with its loss fostering the CSC compartment in both solid and hematologic malignancies. CSCs are responsible for tumor propagation, metastatic spread, resistance to therapy, and relapse. Thus, understanding how alterations of <i>PTEN</i> levels affect CSC hallmarks could be crucial for the development of successful therapeutic approaches. Here, we discuss the most significant findings on <i>PTEN</i>-mediated control of CSC state. We aim to unravel the role of <i>PTEN</i> in the regulation of key mechanisms specific for CSCs, such as self-renewal, quiescence/cell cycle, Epithelial-to-Mesenchymal-Transition (EMT), with a particular focus on <i>PTEN</i>-based therapy resistance mechanisms and their exploitation for novel therapeutic approaches in cancer treatment.https://www.mdpi.com/2072-6694/11/8/1076cancer stem cellsPTENtherapy resistancetargeted therapy
spellingShingle Francesca Luongo
Francesca Colonna
Federica Calapà
Sara Vitale
Micol E. Fiori
Ruggero De Maria
PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
Cancers
cancer stem cells
PTEN
therapy resistance
targeted therapy
title PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
title_full PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
title_fullStr PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
title_full_unstemmed PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
title_short PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
title_sort pten tumor suppressor the dam of stemness in cancer
topic cancer stem cells
PTEN
therapy resistance
targeted therapy
url https://www.mdpi.com/2072-6694/11/8/1076
work_keys_str_mv AT francescaluongo ptentumorsuppressorthedamofstemnessincancer
AT francescacolonna ptentumorsuppressorthedamofstemnessincancer
AT federicacalapa ptentumorsuppressorthedamofstemnessincancer
AT saravitale ptentumorsuppressorthedamofstemnessincancer
AT micolefiori ptentumorsuppressorthedamofstemnessincancer
AT ruggerodemaria ptentumorsuppressorthedamofstemnessincancer